PF-Atlas › Clinical Trials › NCT03843723

Cystic Fibrosis and Fit-to-Fly

Pre-flight evaluation · Not specified

Registry ID
NCT03843723
Phase
Not specified
Status
Completed
Drug / intervention
Pre-flight evaluation
Sponsor
Oslo University Hospital
Start
2019-03-01
Enrollment
79
Locations
1

About this trial

Due to the hypobaric hypoxia during air travel, some patients with Cystic Fibrosis (CF) need supplemental oxygen during air travel. The study aims to evaluate if adding exercise desaturation to the pre-flight evaluation will help predict requirements for in-flight supplemental oxygen.

View NCT03843723 on ClinicalTrials.gov →

Explore related

All Pre-flight evaluation trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT03843723 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.